PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32726663-0	2020	Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib.	Folic Acid	25-31	5' nucleotidase, ecto	Mus musculus	14-18	
32726663-0	2020	Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib.	Folic Acid	25-31	5' nucleotidase, ecto	Mus musculus	69-73	
32726663-7	2020	So in this study, we intended to simultaneously suppress CD73 and CDKs in cancer cells by using the folic acid (FA)-conjugated chitosan-lactate (CL) NPs loaded with anti-CD73 siRNA and Dinaciclib to control tumor progression and metastasis.	Folic Acid	100-110	5' nucleotidase, ecto	Mus musculus	57-61	
32726663-7	2020	So in this study, we intended to simultaneously suppress CD73 and CDKs in cancer cells by using the folic acid (FA)-conjugated chitosan-lactate (CL) NPs loaded with anti-CD73 siRNA and Dinaciclib to control tumor progression and metastasis.	Folic Acid	100-110	5' nucleotidase, ecto	Mus musculus	170-174